Consulting Market Access

Odelle Technology provides specialist market access support for health-technology companies developing medtech, in vitro diagnostics, digital health, AI-enabled healthcare, biotech, pharma, companion diagnostics, surgical technologies and implantable devices.  The service helps EIC beneficiaries and other health-technology innovators understand how their product can move from clinical or technical validation into reimbursement, adoption and commercial use across Europe, the UK and selected international markets. Odelle supports companies with country sequencing, market-entry strategy, reimbursement pathway mapping, payer and hospital stakeholder analysis, clinical pathway positioning, evidence-gap assessment, comparator strategy, pricing and budget-impact logic, HTA readiness, coding and payment-route analysis, and preparation of payer-facing value narratives.  The service may include written market access reports, country-by-country route maps, evidence-to-adoption frameworks, reimbursement-readiness assessments, pricing-risk profiles, hospital budget-risk analysis, stakeholder engagement materials, and board-ready strategic recommendations.  Odelle’s approach is tailored to each technology and stage of development, including pre-CE planning, PMCF, real-world evidence generation, clinical validation, reimbursement preparation, hospital adoption and investor due diligence. The objective is to help companies define the right patient group, comparator, evidence plan, market sequence and value argument so that innovation is not only clinically promising, but also adoptable, fundable and commercially defensible.